share_log

ElectroCore, Inc. (NASDAQ:ECOR) to Post Q4 2022 Earnings of ($0.07) Per Share, Brookline Capital Management Forecasts

Defense World ·  Jan 16, 2023 02:11

electroCore, Inc. (NASDAQ:ECOR – Get Rating) – Equities researchers at Brookline Capital Management issued their Q4 2022 EPS estimates for shares of electroCore in a note issued to investors on Thursday, January 12th. Brookline Capital Management analyst K. Dolliver forecasts that the company will post earnings of ($0.07) per share for the quarter. Brookline Capital Management currently has a "Buy" rating on the stock. The consensus estimate for electroCore's current full-year earnings is ($0.30) per share. Brookline Capital Management also issued estimates for electroCore's Q1 2023 earnings at ($0.07) EPS, Q2 2023 earnings at ($0.09) EPS, Q3 2023 earnings at ($0.04) EPS and Q4 2023 earnings at ($0.06) EPS.

Get electroCore alerts:

electroCore (NASDAQ:ECOR – Get Rating) last posted its earnings results on Thursday, November 3rd. The company reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.01). electroCore had a negative return on equity of 72.36% and a negative net margin of 283.41%. The business had revenue of $1.98 million for the quarter.

Several other analysts also recently commented on ECOR. Brookline Capital Acquisition started coverage on shares of electroCore in a report on Friday. They issued a "buy" rating for the company. Berenberg Bank cut their target price on shares of electroCore from GBX 390 ($4.75) to GBX 330 ($4.02) and set a "buy" rating for the company in a research report on Thursday, October 6th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, electroCore currently has an average rating of "Buy" and an average price target of $111.42.

electroCore Stock Up 1.1 %

electroCore stock opened at $0.30 on Monday. electroCore has a 12-month low of $0.20 and a 12-month high of $0.90. The firm's fifty day moving average is $0.30 and its 200 day moving average is $7.80. The company has a market capitalization of $21.49 million, a PE ratio of -0.97 and a beta of 0.93.

Insiders Place Their Bets

In other news, Director Joseph P. Errico bought 100,000 shares of the firm's stock in a transaction that occurred on Tuesday, December 13th. The shares were bought at an average cost of $0.33 per share, with a total value of $33,000.00. Following the completion of the purchase, the director now directly owns 2,724,841 shares in the company, valued at $899,197.53. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders have acquired 670,000 shares of company stock valued at $186,650. 13.11% of the stock is currently owned by corporate insiders.

Institutional Trading of electroCore

Hedge funds have recently modified their holdings of the business. Valeo Financial Advisors LLC boosted its stake in electroCore by 1.2% in the 2nd quarter. Valeo Financial Advisors LLC now owns 1,844,500 shares of the company's stock worth $941,000 after purchasing an additional 22,250 shares in the last quarter. Jaffetilchin Investment Partners LLC boosted its holdings in shares of electroCore by 31.6% in the first quarter. Jaffetilchin Investment Partners LLC now owns 307,984 shares of the company's stock worth $82,000 after buying an additional 74,000 shares during the last quarter. Millennium Management LLC boosted its position in shares of electroCore by 173.3% in the second quarter. Millennium Management LLC now owns 119,707 shares of the company's stock worth $61,000 after purchasing an additional 75,908 shares during the period. Virtu Financial LLC bought a new position in shares of electroCore in the first quarter worth approximately $53,000. Finally, Renaissance Technologies LLC boosted its position in shares of electroCore by 102.2% in the second quarter. Renaissance Technologies LLC now owns 262,848 shares of the company's stock worth $134,000 after purchasing an additional 132,848 shares during the period. Institutional investors own 17.76% of the company's stock.

electroCore Company Profile

(Get Rating)

electroCore, Inc, a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.

Featured Stories

  • Get a free copy of the StockNews.com research report on electroCore (ECOR)
  • General Electric Stock, The Sum of All Parts Strategy is Paying Off
  • MarketBeat: Week in Review 01/09-01/13
  • JPMorgan Chase Falls As Banks Brace For Recession
  • Why is the Bed Bath & Beyond Stock Price up 261%?
  • Roku Stock Price is Trending, Here's Why

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment